Low‐level gastrokine 2 promoted progress of NSCLC and as a potential biomarker

BACKGROUND: Gastrokine 2 (GKN2) is significantly downregulated in non‐small cell lung cancer (NSCLC) tissues than in normal tissues (NT), as assessed by mRNA microassay; however, the mechanism and clinical value of GKN2 is unknown in NSCLC. METHODS: A total of 60 NSCLC samples and corresponding NT s...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xiang, Shi, Wenjing, Zhou, Huixin, Huang, Xiaolou, Hu, Lijuan, Feng, Jiang, Wang, Yumin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841183/
https://www.ncbi.nlm.nih.gov/pubmed/34970791
http://dx.doi.org/10.1002/jcla.24213

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841183/
https://www.ncbi.nlm.nih.gov/pubmed/34970791
http://dx.doi.org/10.1002/jcla.24213

Ejemplares similares